Condition: Acute Coronary Syndrome · Sponsor: Pontificia Universidad Catolica de Chile
This randomized clinical trial will determine the treatment effect of colchicine (1.5 mg loading dose and 0.5 mg daily thereafter) for 6 weeks on microvascular coronary reperfusion and infarct size in patients with acute coronary syndrome.
This description comes directly from the study's public registry record.
Gonzalo Martínez, MD · 56 223543218 · gmartinezr@med.puc.cl
Maria Paz Orellana · 011 56 979683630 · mporella@uc.cl
Always discuss trial participation with your own doctor first.
| Hospital Clínico Pontificia Universidad Catolica de Chile | Santiago, Santiago Metropolitan, Chile | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05472337